Melissa crowned Pulp Idol for teen pregnancy novel
UP-and-coming novelist Melissa Grindon hailed LJMU's writing community after being crowned Pulp Idol by Liverpool literary organisation, Writing on the Wall.
UP-and-coming novelist Melissa Grindon hailed LJMU's writing community after being crowned Pulp Idol by Liverpool literary organisation, Writing on the Wall.
22 universities, including Liverpool John Moores University and JMSU have pledged to develop a Student Futures Manifesto joint action between a university and its students to improve the student experience.
An LJMU researcher is part of an international team of researchers who have put forward a position statement, published in Science, which lays out a new healthcare framework to help ageing populations stay healthier for longer.
The prestigious titles are awarded to those who have made an outstanding contribution to society, or an outstanding achievement by an individual in a given field, resonating with the ethos and values of the university and the city of Liverpool.
Researchers at Liverpool John Moores University are set to investigate a worrying phenomenon in the North West of England that is seeing increasing numbers of vulnerable children placed into local authority care yet remain living at home.
From community sports clubs that support people with special educational needs to premier league football clubs, 173 students have undertaken 14,730 hours of work-based placements this academic year.
Liverpool John Moores University, in partnership with the University of Liverpool, are set to host a new £1.3million Centre for Doctoral Training providing comprehensive postgraduate training in data intensive science.
Thousands employed in the fishing industry face debt and financial hardship, according to findings from the Research Unit for Financial Inclusion at Liverpool John Moores University.
A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.
Research finds natural proteins block SARS-CoV-2 from entering human cells